ANN ARBOR – Marty Makary, head of the U.S. Food and Drug Administration (FDA) reported the agency will not interfere with a new federal policy providing Medicare beneficiaries coverage for hemp-derived CBD products.
Makary said while the agency preserves its authority to regulate products containing hemp or hemp-derived compounds under the Food, Drug and Cosmetic (FD&C) Act, it will loosen its “enforcement posture” for certain CBD products eligible under the Centers for Medicare and Medicaid Services’ (CMS) CBD pilot program that commenced on April 1.
Kyle McCalmon, co-owners of Thumb Coast CBD in St. Clair, joins Mike Brennan, editor of MITechNews, and Dave Crabill, iHemp Michigan board member, on this episode of Michigan Marijuana Today to explain what this means for CBD…